Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA
Stock Information for Oncolytics Biotech Inc.
Loading
Please wait while we load your information from QuoteMedia.